Jeet Mukherjee
Stock Analyst at BTIG
(2.16)
# 3,276
Out of 5,134 analysts
179
Total ratings
39.1%
Success rate
0.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FHTX Foghorn Therapeutics | Maintained: Hold | n/a | $2.04 | - | 7 | Nov 10, 2026 | |
| IBRX ImmunityBio | Maintained: Buy | $12 | $7.11 | +68.90% | 10 | Nov 10, 2026 | |
| CATX Perspective Therapeutics | Maintained: Buy | $14 | $0.8585 | +1,530.75% | 12 | Nov 10, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $29 | $14.16 | +104.80% | 7 | Nov 10, 2026 | |
| BCAX Bicara Therapeutics | Maintained: Buy | $39 → $37 | $9.99 | +270.37% | 10 | Nov 10, 2026 | |
| FTH Faeth Therapeutics | Reiterated: Buy | $55 | $12.67 | +334.10% | 9 | Nov 9, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $48 | $15.36 | +212.50% | 6 | Nov 5, 2026 | |
| IPHA Innate Pharma | Reiterated: Buy | $9 | $1.47 | +512.24% | 8 | Nov 5, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $215 | $175.07 | +22.81% | 12 | Nov 5, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $14 | $3.91 | +258.51% | 2 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $6.76 | +166.27% | 13 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $16.13 | +98.39% | 13 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $8.69 | +176.18% | 10 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $139 | $139.18 | -0.13% | 15 | Nov 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $28.98 | +331.33% | 7 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $9.22 | +182.00% | 3 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.36 | - | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 → $133 | $73.31 | +81.42% | 17 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.56 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $24.32 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.1828 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $51.55 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $12.76 | n/a | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $32.03 | n/a | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0002 | n/a | 1 | Apr 1, 2025 |
Foghorn Therapeutics
Nov 10, 2026
Maintained: Hold
Price Target: n/a
Current: $2.04
Upside: -
ImmunityBio
Nov 10, 2026
Maintained: Buy
Price Target: $12
Current: $7.11
Upside: +68.90%
Perspective Therapeutics
Nov 10, 2026
Maintained: Buy
Price Target: $14
Current: $0.8585
Upside: +1,530.75%
ArriVent BioPharma
Nov 10, 2026
Maintained: Buy
Price Target: $29
Current: $14.16
Upside: +104.80%
Bicara Therapeutics
Nov 10, 2026
Maintained: Buy
Price Target: $39 → $37
Current: $9.99
Upside: +270.37%
Faeth Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $55
Current: $12.67
Upside: +334.10%
Ascentage Pharma Group International
Nov 5, 2026
Reiterated: Buy
Price Target: $48
Current: $15.36
Upside: +212.50%
Innate Pharma
Nov 5, 2026
Reiterated: Buy
Price Target: $9
Current: $1.47
Upside: +512.24%
Palvella Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $215
Current: $175.07
Upside: +22.81%
Quoin Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $14
Current: $3.91
Upside: +258.51%
Nov 3, 2026
Reiterated: Buy
Price Target: $18
Current: $6.76
Upside: +166.27%
Nov 3, 2026
Reiterated: Buy
Price Target: $32
Current: $16.13
Upside: +98.39%
Nov 2, 2026
Reiterated: Buy
Price Target: $24
Current: $8.69
Upside: +176.18%
Nov 1, 2026
Reiterated: Buy
Price Target: $139
Current: $139.18
Upside: -0.13%
Oct 29, 2026
Reiterated: Buy
Price Target: $125
Current: $28.98
Upside: +331.33%
Oct 27, 2026
Reiterated: Buy
Price Target: $26
Current: $9.22
Upside: +182.00%
Aug 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.36
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: $117 → $133
Current: $73.31
Upside: +81.42%
May 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.56
Upside: n/a
May 23, 2025
Reiterated: Buy
Price Target: $91
Current: $24.32
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $12
Current: $0.1828
Upside: n/a
May 13, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $51.55
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $100
Current: $12.76
Upside: n/a
Apr 14, 2025
Reiterated: Buy
Price Target: $62
Current: $32.03
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a